Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
2.720
+0.080 (3.03%)
Mar 4, 2026, 2:38 PM EST - Market open
Immutep Market Cap
Immutep has a market cap or net worth of $369.5 million as of March 4, 2026. Its market cap has increased by 29.78% in one year.
Market Cap
369.50M
Enterprise Value
300.34M
1-Year Change
29.78%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since April 19, 2012, Immutep's market cap has increased from $74.60M to $369.50M, an increase of 395.30%. That is a compound annual growth rate of 12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 389.10M | -6.85% |
| Dec 31, 2025 | 417.70M | 32.52% |
| Dec 31, 2024 | 315.20M | 10.60% |
| Dec 29, 2023 | 285.00M | 87.99% |
| Dec 30, 2022 | 151.60M | -38.22% |
| Dec 31, 2021 | 245.40M | 60.29% |
| Dec 31, 2020 | 153.10M | 152.22% |
| Dec 31, 2019 | 60.70M | 8.98% |
| Dec 31, 2018 | 55.70M | 70.34% |
| Dec 29, 2017 | 32.70M | 125.52% |
| Dec 30, 2016 | 14.50M | -27.50% |
| Dec 31, 2015 | 20.00M | 143.90% |
| Dec 31, 2014 | 8.20M | -29.91% |
| Dec 31, 2013 | 11.70M | -68.03% |
| Dec 31, 2012 | 36.60M | -50.94% |
| Apr 19, 2012 | 74.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 422.10M |
| Century Therapeutics | 416.78M |
| Upstream Bio | 415.02M |
| Enanta Pharmaceuticals | 414.98M |
| Absci | 412.02M |
| Anavex Life Sciences | 410.54M |
| Niagen Bioscience | 404.45M |
| PureTech Health | 399.43M |